Pathogenic mechanisms, diagnostic, and therapeutic potential of microvesicles in diabetes and its complications

Alaa Abbas1, Heba Almaghrbi1, Roberta Giordo2

  • 1Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.

PubMed

Insights

Microvesicles (MVs) are key in diabetes and its complications, mediating cell communication. Research explores MVs

Area of Science:

  • Biomedical Sciences
  • Cell Biology
  • Endocrinology

Background:

  • Extracellular vesicles (EVs), especially microvesicles (MVs), are crucial for intercellular communication.
  • Their roles in physiological and pathological states, including diabetes mellitus (DM) and its complications, are increasingly recognized.

Purpose of the Study:

  • To comprehensively review the emerging roles of MVs in the pathogenesis of diabetes and its complications.
  • To examine the molecular mechanisms and potential clinical applications of MVs in diabetes.

Main Methods:

  • Literature review focusing on MVs in diabetes pathogenesis.
  • Analysis of MVs' cargo (proteins, lipids, nucleic acids) and their regulatory functions.
  • Discussion of current challenges and future directions in MV research.

Main Results:

  • MVs contribute to diabetes complications like nephropathy, retinopathy, cardiomyopathy, and neuropathy.
  • MV cargo regulates inflammation, oxidative stress, immune responses, and tissue remodeling, driving disease progression.
  • MVs show potential as biomarkers for diagnosis and as drug delivery vehicles.

Conclusions:

  • MVs play a significant role in the pathogenesis of diabetes and its complications.
  • Further research is needed to overcome challenges in MV isolation, characterization, and clinical validation.
  • Advanced techniques and improved methods are essential for translating MVs into clinical applications for improved diabetes patient outcomes.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
894
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
515
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K